Consort Medical plc (LON:CSRT) insider Ian James Nicholson acquired 1,350 shares of the stock in a transaction that occurred on Friday, August 9th. The stock was acquired at an average cost of GBX 736 ($9.62) per share, with a total value of £9,936 ($12,983.14).
LON:CSRT opened at GBX 726 ($9.49) on Thursday. Consort Medical plc has a 1-year low of GBX 700 ($9.15) and a 1-year high of GBX 1,270 ($16.59). The business has a 50-day simple moving average of GBX 794.58. The stock has a market capitalization of $353.45 million and a price-to-earnings ratio of 34.25. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 46.56.
The firm also recently disclosed a dividend, which will be paid on Friday, October 25th. Investors of record on Thursday, September 19th will be paid a GBX 13.80 ($0.18) dividend. The ex-dividend date of this dividend is Thursday, September 19th. This is a positive change from Consort Medical’s previous dividend of $7.60. This represents a yield of 1.53%. Consort Medical’s dividend payout ratio is 1.32%.
Consort Medical Company Profile
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.
Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.